NLA_SS_Web Banner Mockup (1).jpg

2022 NLA Scientific Sessions Abstracts

Click on the posters to see an enlarged version, or scan the QR Codes with your phone to have a touch-free experience. 

Sex Disparities in Treatment and Outcomes of Patients with Familial Hypercholesterolemia

Presenting Author: Amanda Guerin
Authors: Iulia Iatan, Isabelle Ruel, Linda Ngufor, Jacques Genest

NLAUpdate6.jpg
NLA_Update6.png

Kiosk 1

Pregnancy-Induced Hypertension: The Potential Role of Cholesterol Crystals in the Maternal Decidua

Presenting Author: Robert Wild
Authors: Robert Wild, Carolyn M. Salafia, Nigel Paneth, Ruchit Shah, Ma T, Tracy Thomas,George S. Abela

Poster 2.jpg
NLA_Poster_2.png

Kiosk 2

Characterization of inclisiran use in real world: Prescription data from Germany

Presenting Author: Jason Lecocq
Authors: Raquel Lahoz, Sven Klebs, Christian Mann, Jason Lecocq, Rebecca Zingel, Divyagiri Seshagiri

press to zoom

press to zoom

press to zoom
1/2
NLA_Poster_3.png

Kiosk 2

A Randomized Study to Evaluate the Effect of an “Inclisiran First” Implementation Strategy vs Usual Care in Patients with Atherosclerotic Cardiovascular Disease and Elevated Low-Density Lipoprotein Cholesterol: Rationale and Design of the VICTORION-INITIATE Trial

Presenting Author: Michael Koren
Authors: Michael Koren, Cara East, Fatima Rodriguez, Robert Stoekenbroek, Dion Zappe, Peter P. Toth, Jennifer Robinson

press to zoom

press to zoom

press to zoom

press to zoom
1/3
NLA_Poster_3b (1).png

Kiosk 2

Novel Use of Therapeutic Plasma Exchange and Evinacumab in a Patient with Homozygous Familial Hypercholesterolemia

Presenting Author: Alexandra Sykes
Authors: Amber P. Sanchez, Joseph L. Witztum, Michael J. Wilkinson

press to zoom

press to zoom

press to zoom

press to zoom
1/3
Poster_5 (1).png

Kiosk 2

Cardiovascular risk factors in a true incident ACS population

Presenting Author: Richard Amoateng
Authors: Andrew Oehler

press to zoom

press to zoom

press to zoom

press to zoom
1/6
NLA_Poster_6.png

Kiosk 3

Lipid-Lowering Therapy for Primary Prevention of Cardiovascular Disease: A Nationwide Analysis of 412,913 Patients

Presenting Author: Ahmed Kolkailah
Authors: Ahmed A. Kolkailah, Eric D. Peterson, Anand Gupta, Yiqing Wang, Kristin Gillard, Marc K. Israel, Ann Marie Navar

Poster 7.jpg
NLA_Poster_7.png

Kiosk 3

Universal screening for familial hypercholesterolaemia in two populations

Presenting Author: Urh Groselj
Authors: Ursa Sustar, Matej Mlinaric, Jernej Kovac, Stefan Arens, Katarina Sedej, Barbara Jenko Bizjan, Katarina Trebusak Podkrajsek, Thomas Danne, Tadej Battelino, Olga Kordonouri

Poster 9.jpg
NLA_Poster_9.png

Kiosk 3

A CLINICALLY VALIDATED GENETIC TESTING FOR FAMILIAL HYPERCHOLESTEROLEMIA IN QUEBEC: A SINGLE CENTER RETROSPECTIVE COHORT STUDY

Presenting Author: Iulia Iatan
Authors: Iulia Iatan, Amanda Guerin, Isabelle Ruel, Jean-Baptiste Rivière, Linda Ngufor, Jacques Genest

NLAUpdate5.jpg
NLA_Poster_Update4.png

Kiosk 3

Mesenchymal Stromal Cells (MSCs) upregulated with antioxidant SOD2 improve non alcoholic fatty liver disease (NAFLD) in long term diet induced obesity (DIO) mouse model.

Presenting Author: Sabyasachi Sen
Authors: Seshagiri Rao Nandula, Sabyasachi Sen

5-19-2022--FINAL-NLA-poster-SS-page-001.jpg
NLA_Poster_10.png

Kiosk 4

Acquired Chylomicronemia Due To Autoantibodies Against GPIHBP1

Presenting Author: Chad Morreale
Authors: Mansi Katkar, Namra Butt, Alan Brown

Poster 11.jpg
NLA_Poster_11.png

Kiosk 4

Severe Hypertriglyceridemia as a Cause of Arterial Thrombosis with Peripheral Embolic Complications.

Presenting Author: Maya Safarova

NLAUpdate4.jpg
NLA_Add2.png

Kiosk 4

Improvement in Housestaff Knowledge of Novel Antihyperglycemic Agents Through a Cross-Specialty "Beyond Diabetes" Educational Initiative

Presenting Author: Spencer Weintraub
Authors: Hosam Hmoud MD, Jamie Hirsch MD, Agnes Cha PharmD, John Joshua MBA, Eugenia Gianos MD, Benjamin Hirsh MD

Poster 13.jpg
NLA_Poster_13.png

Kiosk 4

Unique case of management of severe hypertriglyceridemia secondary to familial chylomicronemia syndrome

Presenting Author: Sohil Golwala
Authors: Daniel Rader

press to zoom

press to zoom

press to zoom
1/2
NLA_Poster_14.png

Kiosk 5

Lipoprotein X hyperlipidemia and its complications in a patient with primary biliary cholangitis

Presenting Author: Sohil Golwala
Authors: Daniel Soffer

Poster 15.jpg
NLA_Poster_15.png

Kiosk 5

Efficacy and safety of inclisiran in patients with established cerebrovascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised clinical trials

Presenting Author: R. Scott Wright
Authors: Wolfgang Koenig, Kausik K Ray, David G Kallend, Ulf Landmesser, Lawrence A Leiter, Gregory G Schwartz, R Scott Wright, Lorena Garcia Conde, Mark Jaros, Frederick J Raal

press to zoom

press to zoom

press to zoom

press to zoom
1/4
NLA_Poster_18.png

Kiosk 5

Intima-media thickness measured at the common-carotid artery in patients treated with lipoprotein apheresis

Presenting Author: Maya Safarova
Authors: W Jake Thompson, Anne K Nugent, Lauryn Gorby, Julie-Ann Dutton MS, RD, CCRP, Patrick M Moriarty MD

Poster 12.jpg
NLA_Poster_12.png

Kiosk 5

Mysterious case of reduction in HDL cholesterol in a patient with B-cell monocytosis

Presenting Author: Sohil Golwala
Authors: Daniel Soffer

press to zoom

press to zoom

press to zoom
1/2
NLA_Add1.png

Kiosk 5

SAFETY AND EFFICACY OF BEMPEDOIC ACID IN PATIENTS WITH RENAL IMPAIRMENT

Presenting Author: Peter Toth
Authors: Alberico L. Catapano, Lei Lei, Michael J. Louie, George Bakris

18015195 NLA 2022 CKD Poster Layout_final.jpg
NLA_Poster_4.png

Kiosk 6

Racial Difference in Hypertriglyceridemia and Its Impact on Coronary Heart Diseases

Presenting Author: Kyeeun Park
Authors: N. KONINDALA, P. AUNG, K. HIMED

press to zoom

press to zoom

press to zoom
1/2
NLA_Poster_17.png

Kiosk 6

Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10 and ORION-11, Phase III Randomized Controlled Trials

Presenting Author: R. Scott Wright
Authors: Wolfgang Koenig, Kausik K. Ray, David G. Kallend, Ulf Landmesser, Lawrence A. Leiter, Gregory G. Schwartz, R. Scott Wright, Lorena Garcia Conde, Mark Jaros, Frederick J. Raal

press to zoom

press to zoom

press to zoom

press to zoom
1/4
NLA_Poster_16.png

Kiosk 6

The NLRP3 inhibitor and Nrf2 agonist, RRx-001, ameliorates non-alcoholic fatty liver disease in rats

Presenting Author: Bryan Oronsky
Authors: Pedro Cabrales, Scott Caroen, Tony Reid

Poster 19.jpg
NLA_Poster_19.png

Kiosk 7

Association between Metabolic Syndrome and Pulmonary Arterial Hypertension

Presenting Author: Kyeeun Park
Authors: Pyi Phyo Aung, Kyeeun Park, Navya Konindala, Htoo Myat Nge

Association between Metabolic Syndrome and Pulmonary Arterial Hypertension-page-001.jpg
NLA_Poster_20.png

Kiosk 16

Eicosapentaenoic Acid (EPA) Modulates Expression of Inflammatory Proteins in Pulmonary Endothelial Cells following Exposure to Air Pollution Particle Matter

Presenting Author: RP Mason
Authors: Peter Libby, Deepak L. Bhatt, R. Preston Mason

press to zoom

press to zoom

press to zoom

press to zoom
1/5
NLA_Poster_21.png

Kiosk 7

Does Cholesterol Screening in Prader-Willi Syndrome Represent an Opportunity to Reduce Cardiovascular Disease Risk?

Presenting Author: Don Wilson
Authors: Emily Topham, Sani Roy, MD, Luke Hamilton, MS, Don Wilson, MD

press to zoom

press to zoom

press to zoom

press to zoom
1/3
NLA_Poster_22.png

Kiosk 7

Association of Coronary Events with Vessel Burden and Distribution of Coronary Artery Calcification: The Multi-Ethnic Study of Atherosclerosis

Presenting Author: Tara Shrout Allen
Authors: Michael Criqui, Julie Denenberg, Harpreet Bhatia

Poster 23.jpg
NLA_Poster_23.png

Kiosk 8

Coronary Computed Tomography Angiography Evaluation of Plaque Morphology and its Relationship to HDL and Total Cholesterol to HDL Ratio

Presenting Author: Venkat Sanjay Manubolu
Authors: Dhiran Verghese, Luay Alalawi, April Kinninger, Jairo Aldana Bitar, Francesca Calicchio, Christopher Dailing, Khadije Ahmad, Ferdinand Flores, Sion K Roy, Matthew J. Budoff.

Poster 24.jpg
NLA_Poster_24.png

Kiosk 8

Management of atherogenic dyslipidemia in a patient with LDL discordance

Presenting Author: Sohil Golwala
Authors: Douglas Jacoby

Poster 25.jpg
NLA_Poster_25.png

Kiosk 8

Unveiling Compound Heterozygous Familial Hypercholesterolemia

Presenting Author: Sohil Golwala
Authors: Daniel Soffer

press to zoom

press to zoom

press to zoom
1/2
NLA_Poster_Update1.png

Kiosk 8

Effects Of Icosapent Ethyl On Plasma Ceramides And Coronary Plaque Progression In EVAPORATE Trial

Presenting Author: Matthew Ito
Authors: Suvasini Lakshmanan, Lakshmanan S; Benanzer TM; Meeusen J; Donato L; Bhatt DL; Kinninger A; Golub I; Kopecky S; Hyun MC; Scott CG; Nelson JR; Budoff MJ; Ito MK; Jaffe AS; Vasile VC

press to zoom

press to zoom

press to zoom

press to zoom
1/7
NLA_Poster_27.png

Kiosk 9

A Novel ABCG8 Variant and Apo(a) short isoform associated with premature ASCVD and FH phenocopy.

Presenting Author: Loba Alam

Poster 28.jpg
NLA_Poster_28.png

Kiosk 9

Ketogenic Diets Exacerbating Hypercholesterolemia in Patients with Genetic Predisposition

Presenting Author: Loba Alam

Poster 29.jpg
NLA_Poster_29.png

Kiosk 9

EFFICACY AND SAFETY OF BEMPEDOIC ACID IN PATIENTS WITH METABOLIC SYNDROME

Presenting Author: Michael D.Shapiro
Authors: Pam R. Taub, Michael J. Louie, Lei Lei, Christie M. Ballantyne

2022-05-20_NLA MetS POS_FIN-page-001.jpg
NLA_Poster_30.png

Kiosk 10

Genetic architecture and cardiovascular risk of familial combined hyperlipidemia

Presenting Author: Liam Brunham
Authors: Mark Trinder, Diana Vikulova, GB John Mancini, Liam R. Brunham

Poster 31.jpg
NLA_Poster_31.png

Kiosk 10

Intracoronary thrombus in a patient with elevated Lp(a) level and COVID-19

Presenting Author: Laura Kukuc
Authors: Tatiana Echeverry MD, Robert Fishberg MD FACC

Update3.jpg
NLA_Poster_Update2.png

Kiosk 10

Why are Patients Presenting with STEMI Already on Statin not Treated with Additional Aggressive Lipid lowering agents?

Presenting Author: Edward Gill
Authors: Francis Zirille, Michael Morcos, Steve Simon, David Saxon

press to zoom

press to zoom

press to zoom

press to zoom
1/6
NLA_Poster_33.png

Kiosk 11

Barriers and Facilitators to Identification, Cascade Testing, and Treatment for Familial Hypercholesterolemia: A Scoping Review

Presenting Author: Laney Jones
Authors: Gabriela Rodriguez, BS1,2; Evan M. Calvo, BA1,2; Nicole L. Walters, BS2; Andrew Brangan, BS2; Catherine D. Ahmed, MBA3; Mary P. McGowan, MD3,4; Alanna K. Rahm, PhD2; Amy C. Sturm, MS2,5; Laney K. Jones, PharmD, MPH2,6

press to zoom

press to zoom

press to zoom
1/2
NLA_Poster_34.png

Kiosk 11

SAFETY AND EFFICACY OF BEMPEDOIC ACID IN PATIENTS WITH HYPERTENSION

Presenting Author: Keith C. Ferdinand
Authors: Erin D. Michos, P. Benjamin Everett, Lei Lei, Santosh Sanganalmath, Dean G. Karalis

18015262 NLA 2022 HTN Poster_final-1.jpg
NLA_Poster_35.png

Kiosk 11

A Complex Case: Patient with Elevated Lp(a) and Debilitating Stroke

Presenting Author: Jordan Lindekens
Authors: Daniel Soffer

NLA Abstract Poster (pdf)-1.jpg
NLA_Poster_36.png

Kiosk 12

Genetic Testing in Hypertriglyceridemia in Academic Lipid Clinics – Implication for Precision Medicine.

Presenting Author: Matthew Deshotels
Authors: Trevor D. Hadley, MD, Mendel Roth, PhD, Ali M. Agha, MD, Vishnu Priya Pulpati, MD, Anne K. Nugent, MPH, Salim S. Virani, MD, PhD, Vijay Nambi, MD, PhD, Patrick M. Moriarty, MD, Michael H. Davidson, MD, Christie M. Ballantyne, MD

press to zoom

press to zoom

press to zoom

press to zoom
1/6
NLA_Poster_37.png

Kiosk 12

Association of Systemic Inflammation with Lipid Profiles and Management in Patients with Rheumatoid Arthritis

Presenting Author: Avi Aronov
Authors: Yoo Jin Kim, Noreen T Nazir

Poster 38.jpg
NLA_Poster_38.png

Kiosk 12

Marked Hypoleptinemia Precedes Overt Fat Loss In Immune Checkpoint Inhibitor-induced Acquired Generalized Lipodystrophy

Presenting Author: Maheswaran Dhanasekaran
Authors: Rashi Sandooja MD, Alexandra S. Higgins MD, Vinaya Simha MD

press to zoom

press to zoom

press to zoom

press to zoom
1/6
NLA_Poster_39.png

Kiosk 12

The Effect Of CSL112 (Apolipoprotein A-I [Human]) On Cholesterol Efflux Capacity: A Cross-study Comparison

Presenting Author: Serge Korjian
Authors: Bo Zheng, Shinya Goto, Regina Clementi, John Feaster, Danielle Duffy, Penelope Dalitz, Jolanta Airey, John Roberts, Serge Korjian, C. Michael Gibson

Poster 40.jpg
NLA_Poster_40.png

Kiosk 13

BEMPEDOIC ACID PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY IN A PHASE 1 CLINICAL TRIAL IN HEALTHY JAPANESE, WHITE, AND CHINESE SUBJECTS

Presenting Author: Benny M. Amore
Authors: Rujun Teng, Jeffrey C. Hanselman

2022-05-20_NLA 063 POS_FIN-1.jpg
NLA_Poster_41.png

Kiosk 13

The Effect of Estrogen and Testosterone on Cholesterol Crystallization

Presenting Author: Enhua Wang
Authors: Enhua Wang, Abdullah Al-Abcha, Heba Osman, Ayowale Oladeji, Manel Boumegouas, George S. Abela

Poster 42.jpg
NLA_Poster_42.png

Kiosk 13

Socioeconomic Disparities in Dyslipidemia and Associated Complications

Presenting Author: Kyeeun Park
Authors: N. KONINDALA, P. AUNG

press to zoom

press to zoom

press to zoom

press to zoom
1/3
NLA_Poster_43.png

Kiosk 13

Characterization of Lp(a) Measurement In a Large U.S. Health Care Dataset

Presenting Author: Diane MacDougall
Authors: M.P. McGowan, K.A. Wilemon, C.D. Ahmed, K.D. Myers

Poster 44.jpg
NLA_Poster_44.png

Kiosk 14

RATE OF 30-DAY READMISSION & ECONOMIC BURDEN OF PATIENTS WITH ACUTE CONGESTIVE HEART FAILURE WITH COEXISTING METABOLIC SYNDROME

Presenting Author: Michael Fatuyi
Authors: Pereira L 1, Khoklov L1, Namdarizandi V 1, Elabidin A 1, Sharma V 1, Orji R, Busari O, Shemisa K

Poster 45.jpg
NLA_Poster_45.png

Kiosk 14

GOULD EDU: Primary Results of a Cluster-Randomized Trial of an Educational Intervention to Improve Guideline Adherence and Intensification of Lipid-Lowering Therapy

Presenting Author: Christie Ballantyne
Authors: Mikhail N. Kosiborod MD, Christie M. Ballantyne MD, Deepak L. Bhatt MD MPH, James A. de Lemos MD, Qi Gao MS, Naishu Kui MS, Robert S. Rosenson MD, Katherine E. Mues PhD MPH, Jason Exter PharmD, Shushama Alam PharmD, Christopher P. Cannon MD

press to zoom

press to zoom

press to zoom
1/2
NLA_Poster_46.png

Kiosk 15

Universal screening for familial hypercholesterolaemia in two populations

Presenting Author: Urh Groselj
Authors: Ursa Sustar, Matej Mlinaric, Jernej Kovac, Stefan Arens, Katarina Sedej, Barbara Jenko Bizjan, Katarina Trebusak Podkrajsek, Thomas Danne, Tadej Battelino, Olga Kordonouri

Poster 9.jpg
NLA_Poster_9.png

Kiosk 15

Association Between Dietary Fat Content and Serum Lipoprotein(a) Level

Presenting Author: Nimai Patel
Authors: Eric Brandt

press to zoom

press to zoom

press to zoom

press to zoom
1/6
NLA_Poster_47.png

Kiosk 15

Effects Of Icosapent Ethyl On Plasma Ceramides And Coronary Plaque Progression In EVAPORATE Trial

Presenting Author: Suvasini Lakshmanan
Authors: Lakshmanan S; Benanzer TM; Meeusen J; Donato L; Bhatt DL; Kinninger A; Golub I; Kopecky S; Hyun MC; Scott CG; Nelson JR; Budoff MJ; Ito MK; Jaffe AS; Vasile VC

press to zoom

press to zoom

press to zoom

press to zoom
1/7
NLA_Posters_48.png

Kiosk 15

Comparing Prescribing Practices Of Statin Therapy In ASCVD Patients With Varying Levels of CKD

Presenting Author: Armen Fstkchian
Authors: Joseph Saseen, Rachel Lowe

press to zoom

press to zoom

press to zoom

press to zoom
1/7
NLA_Poster_49.png

Kiosk 16

An Unsolved Case: FH or Sitosterolemia?

Presenting Author: Juliette Logan
Authors: Michael Parker Ayers, MD

press to zoom

press to zoom

press to zoom

press to zoom
1/7
NLA_Poster_50.png

Kiosk 18